The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment

Parasitology Today

Volumn 14, Issue 11, 1998, Pages 462-467

  Snounou, Georges ^a   Beck, Hans Peter ^b  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; QUININE; VACCINE;

BLOOD SMEAR; DIFFERENTIAL DIAGNOSIS; DRUG RESISTANCE; GENOTYPE; HUMAN; INOCULATION; MALARIA FALCIPARUM; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; REINFECTION; REVIEW; SCREENING; TREATMENT FAILURE;

EID: 0032212925     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(98)01340-4     Document Type: Article

References (50)

1. Plowe C.V.et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J. Infect. Dis. 176:1997;1590-1596.
2. Hyde J.E. The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. Pharmacol. Ther. 48:1990;45-59.
3. Zolg J.W.et al. Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum. Mol. Biochem. Parasitol. 36:1989;253-262.
4. Snewin V.A.et al. Characterisation of the dihydrofolate reductase-thymidylate synthetase gene from human malaria parasites highly resistant to pyrimethamine. Gene. 76:1989;41-52.
5. Cowman A.F.et al. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A. 85:1988;9109-9113.
6. Peterson D.S., Walliker D., Wellems T.E. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. U. S. A. 85:1988;9114-9118.
7. Reeder J.C.et al. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Am. J. Trop. Med. Hyg. 55:1996;209-213.
8. Curtis J.et al. Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania. Trans. R. Soc. Trop. Med. Hyg. 90:1996;678-680.
9. Duraisingh M.T.et al. Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology. 114:1997;205-211.
10. Peel S.A.et al. A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog(pfmdr) of Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 51:1994;648-658.
11. Wilson C.M.et al. Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol. Biochem. Parasitol. 57:1993;151-160.
12. Foote S.J.et al. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell. 57:1989;921-930.
13. Viriyakosol S.et al. Plasmodium falciparum: selective growth of subpopulations from field samples following in vitro culture, as detected by the polymerase chain reaction. Exp. Parasitol. 79:1994;517-525.
14. Färnert A.et al. Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area. Am. J. Trop. Med. Hyg. 56:1997;538-547.
15. Kemp D.J., Cowman A.F., Walliker D. Genetic diversity in Plasmodium falciparum. Adv. Parasitol. 29:1990;75-149.
16. Conway D.J., McBride J.S. Population genetics of Plasmodium falciparum within a malaria hyperendemic area. Parasitology. 103:1991;7-16.
17. Conway D.J., Greenwood B.M., McBride J.S. Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population. Infect. Immun. 60:1992;1122-1127.
18. Felger I.et al. Plasmodium falciparum: extensive polymorphism in merozoite surface antigen 2 alleles in an area with endemic malaria in Papua New Guinea. Exp. Parasitol. 79:1994;106-116.
19. Ntoumi F.et al. Age-dependent carriage of multiple Plasmodium falciparum merozoite surface antigen-2 alleles in asymptomatic malaria infections. Am. J. Trop. Med. Hyg. 52:1995;81-88.
20. Daubersies P.et al. Rapid turnover of Plasmodium falciparum populations in asymptomatic individuals living in a high transmission area. Am. J. Trop. Med. Hyg. 54:1996;18-26.
21. Engelbrecht F.et al. Plasmodium falciparum: malaria morbidity is associated with specific merozoite surface antigen 2 genotypes. Exp. Parasitol. 81:1995;90-96.
22. Contamin H.et al. Different genetic characteristics of Plasmodium falciparum isolates collected during successive clinical malaria episodes in Senegalese children. Am. J. Trop. Med. Hyg. 54:1996;632-643.
23. Ranford-Cartwright L.C.et al. Frequency of cross-fertilization in the human malaria parasite Plasmodium falciparum. Parasitology. 107:1993;11-18.
24. Babiker H.A.et al. Random mating in a natural population of the malaria parasite Plasmodium falciparum. Parasitology. 109:1994;413-421.
25. Babiker H.A.et al. Gene flow and cross-mating in Plasmodium falciparum in households in a Tanzanian village. Parasitology. 111:1995;433-442.
26. Paul R.E.L.et al. Mating patterns in malaria parasite populations of Papua New Guinea. Science. 269:1995;1709-1711.
27. Robert F.et al. Extensive genetic diversity of Plasmodium falciparum isolates collected from patients with severe malaria in Dakar, Senegal. Trans. R. Soc. Trop. Med. Hyg. 90:1996;704-711.
28. Snewin V.A.et al. Polymorphism of the alleles of the merozoite surface antigens MSA1 and MSA2 in Plasmodium falciparum wild isolates from Colombia. Mol. Biochem. Parasitol. 49:1991;265-275.
29. Wooden J.et al. Plasmodium falciparum: a simple polymerase chain reaction method for differentiating strains. Exp. Parasitol. 75:1992;207-212.
30. Felger I., Tavul L., Beck H.P. Plasmodium falciparum: a rapid technique for genotyping the merozoite surface protein 2. Exp. Parasitol. 77:1993;372-375.
31. Prescott N.et al. Plasmodium falciparum genetic diversity can be characterised using the polymorphic merozoite surface antigen 2 (MSA-2) gene as a single locus marker. Mol. Biochem. Parasitol. 63:1994;203-212.
32. Viriyakosol S.et al. Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiological studies. Bull. WHO. 73:1995;85-95.
33. Contamin H.et al. PCR typing of field isolates of Plasmodium falciparum. J. Clin. Microbiol. 33:1995;944-951.
34. Kain K.C., Craig A.A., Ohrt C. Single-strand conformational polymorphism analysis differentiates Plasmodium falciparum treatment failures from re-infections. Mol. Biochem. Parasitol. 79:1996;167-175.
35. Al-Yaman F.et al. Evidence that recurred Plasmodium falciparum infection is caused by recrudescence of resistant parasites. Am. J. Trop. Med. Hyg. 56:1997;436-439.
36. von Seidlein L.et al. Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug CGP 56697. J. Infect. Dis. 176:1997;1113-1116.
37. Irion, A. et al. Distinction of recrudescences from new infections by PCR-RFLP analysis in comparative trial of CGP56697 and chloroquine in Tanzanian children. Trop. Med. Int. Health (in press).
38. Ranford-Cartwright L.C.et al. Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans. R. Soc. Trop. Med. Hyg. 91:1997;719-724.
39. Babiker H.et al. Genetic evidence that RI chloroquine resistance of Plasmodium falciparum is caused by recrudescence of resistant parasites. Trans. R. Soc. Trop. Med. Hyg. 88:1994;328-331.
40. Ohrt C.et al. Distinguishing Plasmodium falciparum treatment failures from reinfections by restriction fragment length polymorphism and polymerase chain reaction genotyping. Am. J. Trop. Med. Hyg. 57:1997;430-437.
41. Beck H.P.et al. Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66. J. Infect. Dis. 175:1997;921-926.
42. Snounou G.et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol. Biochem. Parasitol. 61:1993;315-320.
43. Felger I.et al. Sequence diversity and molecular evolution of the merozoite surface antigen 2 of Plasmodium falciparum. J. Mol. Evol. 45:1997;154-160.
44. Field, J.W. and Shute, P.G. (1956) The Microscopic Diagnosis of Human Malaria. II. A Morphological Study of the Erythrocytic Parasites, Government Press, Kuala Lumpur, Malaysia.
45. Garnham, P.C.C. (1966) in Malaria Parasites and other Haemosporidia, pp 357-430, Blackwell Scientific Publications.
46. Marchiafava, E. and Bignami, A. (1894) On Summer-Autumn Malarial Fevers, The New Sydenham Society.
47. Talliaferro, W.H. (1949) in Malariology. A Comprehensive Survey of all Aspects of this Group of Diseases from a Global Standpoint II (Boyd, M.F., ed.), pp 935-965, W.B. Saunders.
48. Nakazawa S., Kanbara H., Aikawa M. Plasmodium falciparum: recrudescence of parasites in culture. Exp. Parasitol. 81:1995;556-563.
49. Kaminsky R., Chuma F., Wasike R.P. Time-dose-response of Trypanosoma brucei brucei to diminazene (Berenil) and in vitro simulation of drug-concentration-time profiles in cattle plasma. Acta Trop. 54:1993;19-30.
50. Kitchen, S.F. (1949) in Malariology. A Comprehensive Survey of all Aspects of this Group of Diseases from a Global Standpoint II (Boyd, M.F., ed.), pp 966-994, W.B. Saunders.